Advances in PSMA theranostics

The validation of prostate specific membrane antigen (PSMA) as a molecular target in metastatic castration-resistant prostate cancer has stimulated the development of multiple classes of theranostic ligands that specifically target PSMA. Theranostic ligands are used to image disease or selectively d...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeitner, Thomas M., Babich, John W., Kelly, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123266/
https://www.ncbi.nlm.nih.gov/pubmed/35597190
http://dx.doi.org/10.1016/j.tranon.2022.101450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123266/
https://www.ncbi.nlm.nih.gov/pubmed/35597190
http://dx.doi.org/10.1016/j.tranon.2022.101450

Ejemplares similares